Clinical trial
Randomized Controlled Study on the Effect of Pharmacogenomics on Individualized Precise Treatment of Patients With Depression
NCT05669391 is registered in ClinicalTrials.gov with Tongji University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Randomized Controlled Study on the Effect of Pharmacogenomics on Individualized Precise Treatment of Patients With Depression
- Lead sponsor
- Tongji University
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- January 1, 2023
- Completion date
- December 31, 2024
- Enrollment
- 120 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
depression, pharmacogenomics